Fair and equitable access to COVID-19 treatments and vaccines

People within and across countries will have different levels of access to treatments and vaccines for COVID-19. Structural, political, and power imbalances mean lack of access to medicines and vaccines already has a devastating effect on people throughout the world. The COVID-19 pandemic is truly global. Populations who are not usually affected by inequitable access to medicines might now view this issue in a new light. However, this pandemic has disproportionately affected those who are already disadvantaged and will continue to do so, both within and between countries.

This briefing encourages policy makers, regulators, companies, funders, and research institutions to consider ways in which COVID-19 treatments and vaccines can be developed, accessed, and distributed to those who need them in fair and equitable ways.4

Find the policy briefing here.